/LOVFF
LOVFF Stock - Cannara Biotech Inc.
Healthcare|Drug Manufacturers - Specialty & GenericOTC
$1.27-0.16%
$0.00 (-0.16%) • Dec 19
73
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.BUY
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.73
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.100
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $1.40
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for LOVFF
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$1.26 – $1.28
TARGET (TP)$1.46
STOP LOSS$1.17
RISK/REWARD1:1.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.32
52W High$1.42
52W Low$0.48
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $107.32M | $81.75M | $57.26M | $35.84M | $17.02M |
| Gross Profit | $47.22M | $29.79M | $27.23M | $17.33M | $10.30M |
| Gross Margin | 44.0% | 36.4% | 47.6% | 48.4% | 60.5% |
| Operating Income | $22.20M | $10.08M | $11.89M | $4.94M | $257,283 |
| Net Income | $13.08M | $6.44M | $6.95M | $2.31M | $-1,528,143 |
| Net Margin | 12.2% | 7.9% | 12.1% | 6.4% | -9.0% |
| EPS | $0.14 | $0.06 | $0.08 | $0.03 | $-0.02 |
Company Overview
Cannara Biotech Inc., together with its subsidiaries, engages in the indoor cultivation, processing, and sale of cannabis and cannabis-derivated products in Canada. It also offers hemp-based CBD products through e-commerce platform. The company was incorporated in 2017 and is headquartered in Saint-Laurent, Canada.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
LOVFFBeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$0.03
Q4 2025
EPS Surprise History
Q1 24
No data
Q3 24
No data
Q3 24
No data
Q1 25
No data
Q2 25
No data
Q2 25
No data
Q3 25
No data
Q4 25
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | Apr 27, 2026 | — | — | — | — |
Q4 2025 | Nov 24, 2025 | — | $0.03 | — | — |
Q3 2025 | Jul 28, 2025 | — | $0.03 | — | — |
Q2 2025 | Apr 28, 2025 | — | $0.03 | — | — |
Q2 2025 | Apr 25, 2025 | — | $0.02 | — | — |
Q1 2025 | Jan 27, 2025 | — | $0.02 | — | — |
Q3 2024 | Aug 31, 2024 | — | $0.05 | — | — |
Q3 2024 | Jul 23, 2024 | — | $0.02 | — | — |
Q1 2024 | Jan 29, 2024 | — | $-0.03 | — | — |
Q1 2024 | Jan 25, 2024 | — | $0.02 | — | — |
Q3 2023 | Aug 31, 2023 | — | $0.04 | — | — |
Q3 2023 | Jul 27, 2023 | — | $0.02 | — | — |
Q2 2023 | Apr 25, 2023 | — | $-0.01 | — | — |
Q1 2023 | Jan 23, 2023 | — | $0.00 | — | — |
Q3 2022 | Aug 31, 2022 | — | $0.02 | — | — |
Q3 2022 | Jul 27, 2022 | — | $0.01 | — | — |
Q2 2022 | Apr 27, 2022 | — | $-0.01 | — | — |
Q1 2022 | Jan 20, 2022 | — | $-0.00 | — | — |
Q3 2021 | Aug 31, 2021 | — | $0.01 | — | — |
Q2 2021 | May 31, 2021 | — | $0.02 | — | — |
Latest News
Loading news...
Frequently Asked Questions about LOVFF
What is LOVFF's current stock price?
Cannara Biotech Inc. (LOVFF) is currently trading at $1.27 per share. The stock has moved -0.16% today.
What is the analyst price target for LOVFF?
No analyst price targets are currently available for this stock.
What sector is Cannara Biotech Inc. in?
Cannara Biotech Inc. operates in the Healthcare sector, specifically within the Drug Manufacturers - Specialty & Generic industry. The company is traded on the OTC exchange.
What is LOVFF's market cap?
Cannara Biotech Inc. has a market capitalization of $0.12 billion, making it a small-cap company.
Does LOVFF pay dividends?
No, Cannara Biotech Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorBIOYF
BioSyent Inc.
$8.85
Mkt Cap: $0.1B
CBWTF
Auxly Cannabis Group Inc.
$0.11
Mkt Cap: $0.1B
GRUSF
Grown Rogue International Inc.
$0.38
Mkt Cap: $0.1B
HLTRF
HLS Therapeutics Inc.
$3.42
Mkt Cap: $0.1B
KNTPF
Kintor Pharmaceutical Limited
$0.22
Mkt Cap: $0.1B
LRDSF
Lords & Company Worldwide Holdings Inc.
$0.00
Mkt Cap: $0.0B
ORXOF
Orexo AB (publ)
$3.05
Mkt Cap: $0.1B
ORXOY
Orexo AB (publ)
$2.60
Mkt Cap: $0.1B
SHIEF
Shield Therapeutics plc
$0.09
Mkt Cap: $0.1B
STMH
Stem Holdings, Inc.
$0.00
Mkt Cap: $0.0B
Explore stocks similar to LOVFF for comparison